• About Us
  • Our Therapy
    • Clinical and Scientific Publications
  • Our Products
    • HEPZATO KIT™
    • CHEMOSAT®
  • Clinical Trials
  • Investors
  • News
  • Contact
    • Careers

OHSU first in Pacific Northwest to perform revolutionary new cancer treatment procedure

April 16, 2026 | OHSU News

Read more

Watch Key Updates in Metastatic Uveal Melanoma From ESMO 2025

January, 2026 | OncLive

Read more

Retired nurse becomes the first patient at Northwestern Medicine to receive a new treatment for advanced eye cancer that has spread to the liver

Sept 23, 2025 | Newsroom

Read more

How Does Melphalan Treat Uveal Melanoma That Spreads to the Liver?

Jul 28, 2025 |  City of Hope

Read more

Liver-directed Therapy Offers Effective Treatment for Rare Metastatic Uveal Melanoma

July 18, 2025 | Massachusetts General

Read more

Redefining management of uveal melanoma liver metastases: what oncologists need to know

July 17, 2025 | Hospital Healthcare Europe

Read more

No Joke: UCLA Health Team Proves It's Possible to Perform High-Acuity Anesthesia Procedures Outside the OR

December, 2024 | ASA Monitor

Read more

He thought the blurriness in the corner of his eye was part of aging. It was a rare uveal melanoma.

August 22, 2024 | Today

Read more

Novel Procedure Helps Treat Renowned Chef’s Rare Eye Cancer

August 1, 2024 | UCLA Health

Read more

FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma

August 15, 2023 | Moffitt Cancer Center

Read more

Get more information from our dedicated team revolutionizing the treatment of patients with cancers of the liver.

Contact Us

Connect with Us


Email

LinkedIn

YouTube

X

Copyright © 2026 Delcath Systems, Inc. All rights reserved.

Privacy Policy  |  Terms of Use  |  Accessibility